Kitamura Y, Taguchi T, Yokoyama M, Inoue M, Yamatodani A, Asano H, Koyama T, Kanamaru A, Hatanaka K, Wershil B K
Am J Pathol. 1986 Mar;122(3):469-80.
(WB X C57BL/6)F1-W/WV mice possess a genetic defect in multipotential hematopoietic stem cells; the mice are anemic and lack mast cells. The authors injected diluted India ink intravenously into W/WV mice and congenic normal +/+ mice and searched for genetically determined differences in the development of complications of the injection. In both W/WV and +/+ mice, intravenous ink resulted in thrombocytopenia and markedly prolonged bleeding times, as well as prolonged partial thromboplastin and prothrombin times and reduced fibrinogen concentrations. These effects were similar in W/WV and +/+ mice, although the reduction in platelet counts was greater in W/WV mice. In addition, the mortality associated with ink injection was significantly higher in W/WV mice than in congenic +/+ mice. Most W/WV mice which died first exhibited paralysis, and examination under the dissection microscope revealed that ink injection resulted in significantly more cerebral thromboemboli in W/WV mice than in +/+ controls. Bone marrow transplantation from +/+ mice corrected both the mast cell deficiency and the anemia of W/WV mice and protected the W/WV recipients from the adverse consequences of ink injection. By contrast, +/+ mice rendered as anemic as W/WV mice by breeding did not exhibit increased morbidity and mortality after ink injection. (WC X C57BL/6)F1-Sl/Sld mice, which are anemic and lack mast cells because of a genetic defect different from that of W/WV mice, also exhibited increased morbidity and mortality after intravenous ink. Finally, mixture of ink with commercial heparin prior to intravenous injection markedly reduced the incidence of cerebral thromboembolism and death in W/WV mice. Taken together, these findings suggest that the increased morbidity and mortality exhibited by W/WV and Sl/Sld mice that received injected ink might be related to their mast cell deficiency rather than to their anemia. But measurement of the histamine content of the blood and various tissues of WBB6F1-+/+ mice injected with ink, and examination of their tissues in 1-mu sections, indicated that intravenous ink did not cause substantial mast cell degranulation. As a result, the possibility that mast cells protect +/+ mice from the adverse effects of intravenous ink by a mechanism other than degranulation and release of heparin, or that the differences in the response of W/WV or Sl/Sld mice and their +/+ littermates are due to defects other than their lack of mast cells, cannot be excluded.
(WB×C57BL/6)F1-W/WV小鼠在多能造血干细胞方面存在基因缺陷;这些小鼠贫血且缺乏肥大细胞。作者将稀释的印度墨汁静脉注射到W/WV小鼠和同基因正常的+/+小鼠体内,并寻找注射并发症发展过程中由基因决定的差异。在W/WV小鼠和+/+小鼠中,静脉注射墨汁均导致血小板减少、出血时间显著延长,以及部分凝血活酶时间和凝血酶原时间延长、纤维蛋白原浓度降低。这些效应在W/WV小鼠和+/+小鼠中相似,尽管W/WV小鼠的血小板计数下降幅度更大。此外,W/WV小鼠中与墨汁注射相关的死亡率显著高于同基因的+/+小鼠。大多数首先死亡的W/WV小鼠表现出瘫痪,解剖显微镜检查显示,与+/+对照组相比,W/WV小鼠中墨汁注射导致的脑血栓栓塞明显更多。来自+/+小鼠的骨髓移植纠正了W/WV小鼠的肥大细胞缺陷和贫血,并保护W/WV受体免受墨汁注射的不良后果。相比之下,通过育种使+/+小鼠贫血程度与W/WV小鼠相同后,它们在墨汁注射后并未表现出发病率和死亡率增加。(WC×C57BL/6)F1-Sl/Sld小鼠由于与W/WV小鼠不同的基因缺陷而贫血且缺乏肥大细胞,静脉注射墨汁后也表现出发病率和死亡率增加。最后,在静脉注射前将墨汁与商业肝素混合,可显著降低W/WV小鼠脑血栓栓塞和死亡的发生率。综上所述,这些发现表明,接受注射墨汁的W/WV和Sl/Sld小鼠发病率和死亡率增加可能与其肥大细胞缺陷有关,而非与其贫血有关。但是,对注射墨汁的WBB6F1-+/+小鼠血液和各种组织中的组胺含量进行测量,并对其组织进行1微米切片检查,结果表明静脉注射墨汁并未导致肥大细胞大量脱颗粒。因此,不能排除肥大细胞通过除脱颗粒和释放肝素之外的其他机制保护+/+小鼠免受静脉注射墨汁的不良影响,或者W/WV或Sl/Sld小鼠与其+/+同窝小鼠反应差异是由于除缺乏肥大细胞之外的其他缺陷所致的可能性。